Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers: (SurVIC)
Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cavity Squamous Cell Cancers With Advanced Nodal Disease (SurVIC Trial): A Phase 3 Multicentric Randomized Controlled Trial
Sponsor: All India Institute of Medical Sciences, Bathinda
Listed as NCT06737822, this PHASE3 trial focuses on Head and Neck Neoplasms and Oral Cancer and remains actively recruiting participants. Sponsored by All India Institute of Medical Sciences, Bathinda, it has been updated 3 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Apr 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Jan 2025 — Apr 2025 [monthly]
Recruiting PHASE3
First recorded
Dec 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences, Bathinda
- All India Institute of Medical Sciences, Bhubaneswar
- All India Institute of Medical Sciences, Jodhpur
- All India Institute of Medical Sciences, Rishikesh
- Geetanjali Medical College, Udaipur
- King George's Medical University
- Shri Mahant Indiresh Hospital, Dehradun
For direct contact, visit the study record on ClinicalTrials.gov .